Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,577 | -50,874 | -47,185 | -21,214 | -5,796 |
| Depreciation Amortization | 1,149 | 793 | 216 | 707 | 44 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -1,040 |
| Accounts payable and accrued liabilities | -1,390 | 1,124 | -780 | -583 | 101 |
| Other Working Capital | -3,404 | -644 | 2,220 | 1,055 | 117 |
| Other Operating Activity | 10,056 | 10,210 | 14,162 | 4,100 | 4,649 |
| Operating Cash Flow | $-28,166 | $-39,391 | $-31,367 | $-15,935 | $-1,925 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -67,214 | N/A | N/A | N/A |
| PPE Investments | N/A | -38 | -229 | -237 | -3 |
| Sale Of Investment | 33,750 | 33,750 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 50 |
| Other Investing Activity | 42 | -22 | -88 | 123 | 50 |
| Investing Cash Flow | $33,792 | $-33,524 | $-317 | $-114 | $48 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 402 | 403 | N/A | N/A | N/A |
| Debt Issued | 797 | 15,000 | N/A | 2,500 | 1,100 |
| Debt Repayment | -4,583 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 71 | 33,051 | 56,184 | 17,006 | N/A |
| Other Financing Activity | -125 | -1,654 | 0 | 18,444 | 0 |
| Financing Cash Flow | $-3,438 | $46,800 | $56,184 | $37,950 | $1,100 |
| Beginning Cash Position | 22,536 | 48,651 | 24,151 | 2,250 | 811 |
| End Cash Position | 24,724 | 22,536 | 48,651 | 24,151 | 33 |
| Net Cash Flow | $2,188 | $-26,115 | $24,500 | $21,901 | $-778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,166 | -39,391 | -31,367 | -15,935 | -1,925 |
| Capital Expenditure | N/A | -40 | -235 | -237 | -3 |
| Free Cash Flow | -28,166 | -39,431 | -31,602 | -16,172 | -1,928 |